Status:
COMPLETED
Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions:
Arrhythmias, Cardiac
Eligibility:
All Genders
Up to 99 years
Brief Summary
The purpose of this retrospective observational study is to obtain information to confirm or contradict the results of prior studies on domperidone and sudden cardiac death. The population studied are...
Detailed Description
The purpose of this population-based, observational study is to evaluate the combined risk of serious ventricular arrhythmia (irregular heart rhythm) and sudden cardiac death in users of domperidone (...
Eligibility Criteria
Inclusion
- Saskachewan residents who received domperidone or a proton pump inhibitor (PPI) between January 1, 1990, and December 31, 2005
Exclusion
- Cancer free \>=1 year of history in the database before receiving the first dose of domperidone or a PPI
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
1608 Patients enrolled
Trial Details
Trial ID
NCT00925457
Start Date
March 1 2007
End Date
March 1 2009
Last Update
July 19 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.